A detailed history of Texas Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Texas Bank & Trust CO holds 5,002 shares of ABBV stock, worth $1.17 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
5,002
Previous 4,493 11.33%
Holding current value
$1.17 Million
Previous $834 Million 38.87%
% of portfolio
0.44%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$184.85 - $231.54 $94,088 - $117,853
509 Added 11.33%
5,002 $1.16 Billion
Q2 2025

Aug 05, 2025

SELL
$170.16 - $206.27 $322,623 - $391,087
-1,896 Reduced 29.68%
4,493 $834 Million
Q1 2025

May 15, 2025

BUY
$169.2 - $216.66 $7,952 - $10,183
47 Added 0.74%
6,389 $1.34 Billion
Q4 2024

Feb 14, 2025

BUY
$164.99 - $203.87 $1.05 Million - $1.29 Million
6,342 New
6,342 $1.13 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Texas Bank & Trust CO Portfolio

Follow Texas Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Texas Bank & Trust CO with notifications on news.